PubRank

Jeffrey J Olson

Author PubWeight™ 80.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 2010 5.53
2 The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neurooncol 2014 2.32
3 Diagnosis of malignant glioma: role of neuropathology. J Neurooncol 2008 2.23
4 The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2009 2.13
5 The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2009 1.96
6 A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma. Cancer Discov 2012 1.77
7 The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2009 1.70
8 Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One 2010 1.70
9 Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol 2011 1.69
10 Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res 2005 1.67
11 Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion. Neurology 2010 1.49
12 Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism. Cancer Res 2009 1.39
13 Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes. Exp Neurol 2004 1.36
14 Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model. Cancer Res 2006 1.23
15 Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. Cancer Res 2009 1.22
16 Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors. Clin Cancer Res 2004 1.19
17 The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2009 1.13
18 A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neuro Oncol 2002 1.12
19 Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma. J Neurooncol 2010 1.10
20 A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. J Neurooncol 2011 1.09
21 DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. J Cell Mol Med 2009 1.09
22 Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP. Cancer Invest 2011 1.08
23 Rare TP53 genetic variant associated with glioma risk and outcome. J Med Genet 2012 1.07
24 The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2009 1.07
25 An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial. J Neurosurg 2003 1.06
26 Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. J Proteome Res 2007 1.06
27 The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2009 1.04
28 Neuroradiological assessment of newly diagnosed glioblastoma. J Neurooncol 2008 1.03
29 Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review). Int J Oncol 2003 1.01
30 Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP. Clin Cancer Res 2012 0.97
31 RNAi-mediated targeting of noncoding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells. Cancer Res 2012 0.96
32 Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics. Brain Pathol 2013 0.96
33 Neurological and functional outcomes of subdural hematoma evacuation in patients over 70 years of age. J Neurosci Rural Pract 2013 0.96
34 Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery. J Neurooncol 2008 0.94
35 K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas. Cancer Lett 2012 0.93
36 BAI1 regulates spatial learning and synaptic plasticity in the hippocampus. J Clin Invest 2015 0.92
37 Radiolabeled amino acids for tumor imaging with PET: radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid. J Med Chem 2002 0.90
38 Metastasis infiltration: an investigation of the postoperative brain-tumor interface. Int J Radiat Oncol Biol Phys 2010 0.90
39 Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis. Apoptosis 2011 0.89
40 Anthropometric factors in relation to risk of glioma. Cancer Causes Control 2013 0.89
41 Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers. Proteomics 2006 0.89
42 Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection. J Med Chem 2002 0.89
43 Intravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioblastoma. Brain Pathol 2007 0.87
44 Early prediction of response to Vorinostat in an orthotopic rat glioma model. NMR Biomed 2012 0.87
45 Circadian pathway genes in relation to glioma risk and outcome. Cancer Causes Control 2013 0.86
46 Reproductive factors and risk of primary brain tumors in women. J Neurooncol 2014 0.86
47 Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults. J Neurooncol 2008 0.85
48 Delivery systems and molecular targets of mechanism-based therapies for GBM. Expert Rev Neurother 2004 0.85
49 ACR appropriateness criteria on metastatic bone disease. J Am Coll Radiol 2010 0.84
50 Synthesis and evaluation of 2-amino-4-[(18)F]fluoro-2-methylbutanoic acid (FAMB): relationship of amino acid transport to tumor imaging properties of branched fluorinated amino acids. Nucl Med Biol 2003 0.84
51 An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome. Cancer Causes Control 2012 0.84
52 Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors. J Med Chem 2010 0.83
53 Synthesis and biological evaluation of anti-1-amino-2-[18F]fluoro-cyclobutyl-1-carboxylic acid (anti-2-[18F]FACBC) in rat 9L gliosarcoma. Bioorg Med Chem Lett 2010 0.83
54 The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neurooncol 2014 0.82
55 Group independent component analysis and functional MRI examination of changes in language areas associated with brain tumors at different locations. PLoS One 2013 0.82
56 SWI/SNF gene variants and glioma risk and outcome. Cancer Epidemiol 2012 0.81
57 Efficacy of adenoviral p53 delivery with SCH58500 in the intracranial 9l and RG2 models. Front Biosci 2003 0.81
58 The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neurooncol 2014 0.79
59 SSBP2 variants are associated with survival in glioblastoma patients. Clin Cancer Res 2012 0.79
60 Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme. J Neurooncol 2008 0.79
61 Preclinical evaluation of a novel device for delivering brachytherapy to the margins of resected brain tumor cavities. J Neurosurg 2002 0.79
62 Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. J Neurooncol 2012 0.79
63 Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 2005 0.78
64 Synthesis and evaluation of [123I] labeled iodovinyl amino acids syn-, anti-1-amino-3-[2-iodoethenyl]-cyclobutane-1-carboxylic acid, and 1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid as potential SPECT brain tumor imaging agents. Bioorg Med Chem Lett 2008 0.78
65 The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2009 0.78
66 Stereoselective synthesis and biological evaluation of syn-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent. Bioorg Med Chem 2009 0.78
67 Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor. AJR Am J Roentgenol 2014 0.77
68 Magnetic resonance spectroscopic imaging in the era of pseudoprogression and pseudoresponse in glioblastoma patient management. CNS Oncol 2013 0.77
69 Early life exposures and the risk of adult glioma. Eur J Epidemiol 2013 0.77
70 Results of interstitial brachytherapy for malignant brain tumors. Int J Oncol 2002 0.76
71 Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases. J Biol Chem 2012 0.76
72 Prediagnostic body weight and survival in high grade glioma. J Neurooncol 2013 0.75
73 Toenail iron, genetic determinants of iron status, and the risk of glioma. Cancer Causes Control 2013 0.75
74 Safety and efficacy of concurrent interstitial radiation and hyperthermia in the treatment of progressive malignant brain tumors. Oncol Rep 2004 0.75
75 Case study: brain abscess without an obvious source of infection. J Med Assoc Ga 2011 0.75
76 The role of neuropathology in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neurooncol 2014 0.75
77 Clinical practice guidelines in the AANS/CNS Section on Tumors: past, present and future directions. J Neurooncol 2014 0.75